• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Depression - Articles and news items

Amorsa to collaborate with J&J on treatment-resistant depression therapy

Industry news / 5 January 2017 / Niamh Marriott, Digital Editor

Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression…

Novartis’ global study shows 57% of psoriasis patients didn’t reach clear skin treatment goal

Industry news / 3 October 2016 / Niamh Louise Marriott, Digital Content Producer

People with the autoimmune disease, psoriasis, also report that they face discrimination, humiliation, and mental illness…

FDA grants breakthrough therapy designation for depression drug

Industry news / 16 August 2016 / Janssen

Following succesful phase II trials, the FDA have granted a Breakthrough Therapy Designation for esketamine, an investigational antidepressant medication…

Depression symptoms in remission after correcting metabolic deficiencies

Industry news / 12 August 2016 / Niamh Louise Marriott, Digital Content Producer

Searching for answers through a series of biochemical tests, the scientists discovered that the patient had a cerebrospinal fluid deficiency in biopterin, a protein involved in the synthesis of several brain signalling chemicals called neurotransmitters. After receiving an analogue of biopterin to correct the deficiency, the patient’s depression symptoms largely disappeared and today he is a thriving college student. The success prompted the researchers to examine other young adults with depression who were not responding to treatment…